Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Effron

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.
Journal of the American Heart Association|October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 InhibitorsSaket Girotra, Amanda Stebbins, Lisa Wruck, et al.
Circulation. Population Health and Outcomes|February 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health SystemsNishant P Shah, Eric D Peterson, Peter Shrader, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 TrialConnie N Hess, Judith Hsia, Ian A Carroll, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
International Journal of Cardiology|November 5, 2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary interventionMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.
Journal of the American Heart Association|October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 InhibitorsSaket Girotra, Amanda Stebbins, Lisa Wruck, et al.
Circulation. Population Health and Outcomes|February 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health SystemsNishant P Shah, Eric D Peterson, Peter Shrader, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS studyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 TrialConnie N Hess, Judith Hsia, Ian A Carroll, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
International Journal of Cardiology|November 5, 2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary interventionMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
Pageof 10